First Time Loading...
I

Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049

Watchlist Manager
Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
Watchlist
Price: 52.03 CNY 0.7% Market Closed
Updated: May 17, 2024

Inner Mongolia Furui Medical Science Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inner Mongolia Furui Medical Science Co Ltd
Cost of Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
I
Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
Cost of Revenue
-¥269.9m
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
-5%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cost of Revenue
-¥1B
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cost of Revenue
-¥5.7B
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
-24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cost of Revenue
-¥3.8B
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cost of Revenue
-¥28.9B
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cost of Revenue
-¥242.3m
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Inner Mongolia Furui Medical Science Co Ltd's Cost of Revenue?
Cost of Revenue
-269.9m CNY

Based on the financial report for Mar 31, 2023, Inner Mongolia Furui Medical Science Co Ltd's Cost of Revenue amounts to -269.9m CNY.

What is Inner Mongolia Furui Medical Science Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-5%

Over the last year, the Cost of Revenue growth was -6%. The average annual Cost of Revenue growth rates for Inner Mongolia Furui Medical Science Co Ltd have been -3% over the past three years , -2% over the past five years , and -5% over the past ten years .